Full metadata record

DC Field Value Language
dc.contributor.authorEl-Damasy, Ashraf K.-
dc.contributor.authorJin, Heewon-
dc.contributor.authorSabry, Mohamed A.-
dc.contributor.authorKim, Hyun Ji-
dc.contributor.authorAlanazi, Mohammed M.-
dc.contributor.authorSeo, Seon Hee-
dc.contributor.authorBang, Eun-Kyoung-
dc.contributor.authorKeum, Gyochang-
dc.date.accessioned2024-01-19T09:30:39Z-
dc.date.available2024-01-19T09:30:39Z-
dc.date.created2023-07-20-
dc.date.issued2023-06-
dc.identifier.issn1010-660X-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/113637-
dc.description.abstractA new series of 3,4,5-trimethoxyphenyl thiazole pyrimidines has been synthesized and biologically evaluated for its in vitro anticancer activity. Compounds 4a, 4b, and 4h with substituted piperazine showed the best antiproliferative activity. In the NCI-60 cell line screening, compound 4b showed promising cytostatic activity against multiple cell lines. Notably, it elicited a GI value of 86.28% against the NSCL cancer cell line HOP-92 at a 10 & mu;M dose. Compounds 4a and 4h at 10 & mu;M showed promising GI values of 40.87% and 46.14% against HCT-116 colorectal carcinoma and SK-BR-3 breast cancer cell lines, respectively. ADME-Tox prediction of compounds 4a, 4b, and 4h revealed their acceptable drug-likeness properties. In addition, compounds 4a, 4b, and 4h showed a high probability of targeting kinase receptors via Molinspiration and Swiss TargetPrediction.-
dc.languageEnglish-
dc.publisherMDPI-
dc.titleDesign and Synthesis of New 4-(3,4,5-Trimethoxyphenyl)Thiazole-Pyrimidine Derivatives as Potential Antiproliferative Agents-
dc.typeArticle-
dc.identifier.doi10.3390/medicina59061076-
dc.description.journalClass1-
dc.identifier.bibliographicCitationMedicina (Kaunas, Lithuania), v.59, no.6-
dc.citation.titleMedicina (Kaunas, Lithuania)-
dc.citation.volume59-
dc.citation.number6-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid001017150600001-
dc.identifier.scopusid2-s2.0-85163747478-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
dc.type.docTypeArticle-
dc.subject.keywordPlusTYROSINE KINASE INHIBITOR-
dc.subject.keywordPlusBIOLOGICAL EVALUATION-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusDASATINIB-
dc.subject.keywordAuthortrimethoxyphenyl-
dc.subject.keywordAuthorthiazole-
dc.subject.keywordAuthorpyrimidines-
dc.subject.keywordAuthorNCI-60 screening-
dc.subject.keywordAuthorNSCL cancer cell line-
dc.subject.keywordAuthorADME-Tox prediction-
Appears in Collections:
KIST Article > 2023
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE